Biggest News Aggregation in the World
📰 Protein Complex News

Page 2 - Protein Complex News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Protein Complex. Real-time updates on events, politics, business and more.

ImmunoMet Therapeutics Granted Fast Track Designation by U.S. FDA for IM156 in Idiopathic Pulmonary

Search jobs ImmunoMet Therapeutics Granted Fast Track Designation by U.S. FDA for IM156 in Idiopathic Pulmonary Fibrosis HOUSTON--(BUSINESS WIRE)--ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-fibrotic and anti-cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its lead compound IM156, an investigational Protein Complex 1 (PC1) inhibit...
United States Benjamin Cowen Immunomet Therapeutics Inc Drug Administration Immunomet Therapeutics Fast Track

ImmunoMet Therapeutics Receives IND Clearance and Orphan Drug Designation from U.S. FDA for IM156 in Ideopathic Pulmonary Fibrosis and Completes Financing

ImmunoMet Therapeutics Receives IND Clearance and Orphan Drug Designation from U.S. FDA for IM156 in Ideopathic Pulmonary Fibrosis and Completes Financing - Phase 1 clinical study recruitment in healthy volunteers is expected to start in Q1 2021 - - - Recently completed Phase 1 trial in oncology patients demonstrated good safety profile - HOUSTON--(BUSINESS WIRE)--ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-fibrotic and anti-...
United States Benjamin Cowen Immunomet Therapeutics Inc Drug Administration Immunomet Therapeutics Investigational New Drug

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science